Pfizer and its German partner, BioNTech, said Monday that an early analysis showed their three-dose coronavirus vaccine regimen triggered a strong immune response in younger children, proving 80 percent effective at preventing symptomatic infections in children 6 months to 4 years old.
Democracy Dies in Darkness
Pfizer covid shot 80 percent effective in younger kids, early data shows
Updated May 23, 2022 at 4:00 p.m. EDT|Published May 23, 2022 at 6:45 a.m. EDT